Contineum Therapeutics, Inc. Class A Common Stock
Contineum Therapeutics, Inc. Class A Common Stock did not pay dividends during this period.
Total return equals price-only return for non-dividend stocks.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For these stocks, total return equals price appreciation.
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform. The calculation accounts for the compounding effect where reinvested dividends generate their own future dividends.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) delivered a return of -30.69% over the past year. Since CTNM does not currently pay dividends, the total return equals the price-only return.
A $10,000 investment in Contineum Therapeutics, Inc. Class A Common Stock one year ago would be worth $6,931 today, representing a loss of $3,069.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
Screen for dividend stocks with the highest total returns (including DRIP). See which dividend stocks actually grow your wealth.
Calculate total returns for related stocks: